The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function
Open Access
- 19 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10956
Abstract
Highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators have led to dramatic improvements in lung function in many people with cystic fibrosis (PwCF). However, the efficacy of CFTR modulators may be hindered by persistent airway inflammation. The cytokine transforming growth factor-beta1 (TGF-β1) is associated with worse pulmonary disease in PwCF and can diminish modulator efficacy. Thus, strategies to augment the CFTR response to modulators in an inflammatory environment are needed. Here, we tested whether the CFTR amplifier nesolicaftor (or PTI-428) could rescue the effects of TGF-β1 on CFTR function and ciliary beating in primary human CF bronchial epithelial (CFBE) cells. CFBE cells homozygous for F508del were treated with the combination of elexacaftor/tezacaftor/ivacaftor (ETI) and TGF-β1 in the presence and absence of nesolicaftor. Nesolicaftor augmented the F508del CFTR response to ETI and reversed TGF-β1-induced reductions in CFTR conductance by increasing the expression of CFTR mRNA. Nesolicaftor further rescued the reduced ciliary beating and increased expression of the cytokines IL-6 and IL-8 caused by TGF-β1. Finally, nesolicaftor augmented the F508del CFTR response to ETI in CFBE cells overexpressing miR-145, a negative regulator of CFTR expression. Thus, CFTR amplifiers, but only when used with highly effective modulators, may provide benefit in an inflamed environment.Keywords
Funding Information
- Cystic Fibrosis Foundation (SALATH18I0, 003221G221, HL133240, HL139365, HL157942)
- National Heart, Lung, and Blood Institute (SALATH18I0, 003221G221, HL133240, HL139365, HL157942)
This publication has 41 references indexed in Scilit:
- Tgf-β1 Inhibits Cftr Biogenesis and Prevents Functional Rescue of ΔF508-Cftr in Primary Differentiated Human Bronchial Epithelial CellsPLOS ONE, 2013
- CFTR: folding, misfolding and correcting the ΔF508 conformational defectTrends in Molecular Medicine, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Functional Apical Large Conductance, Ca2+-activated, and Voltage-dependent K+ Channels Are Required for Maintenance of Airway Surface Liquid VolumeJournal of Biological Chemistry, 2011
- Transforming growth factor‐β1 in bronchoalveolar lavage fluid from children with cystic fibrosisPediatric Pulmonology, 2009
- Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific FunctionsMolecular & Cellular Proteomics, 2009
- TMEM16A confers receptor-activated calcium-dependent chloride conductanceNature, 2008
- The Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?BioTechniques, 2007
- Chloroquine normalizes aberrant transforming growth factor beta activity in cystic fibrosis bronchial epithelial cellsPediatric Pulmonology, 2006
- Mode of Ca2+ action on ciliary beat frequency in single ovine airway epithelial cellsThe Journal of Physiology, 1999